🇺🇸 FDA
Patent

US 11413255

Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles

granted A61KA61K31/05A61K31/095

Quick answer

US patent 11413255 (Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles) held by Montefiore Medical Center expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Montefiore Medical Center
Grant date
Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/05, A61K31/095, A61K31/12, A61K31/167